Certain NSCLC Subgroups May Not Benefit From Immunotherapy
A comprehensive study exploring NSCLC subgroup responses to immunotherapy may help determine which patients are less likely to benefit from these agents.
Source: medscape.com
Stay updated with breaking news from Mark Gramling. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A comprehensive study exploring NSCLC subgroup responses to immunotherapy may help determine which patients are less likely to benefit from these agents.
GENEVA — The Geneva Lakefront Concert Series is set to return to a full schedule this summer, beginning with next Wednesday’s kickoff.